A pulmonary embolism (PE) occurs when material—most commonly a blood clot—travels through the circulation and lodges in an artery of the lungs, obstructing blood flow. The consequence is impaired oxygen exchange and increased strain on the right side of the heart. Severity ranges from small, clinically silent emboli to large, life-threatening blockages that reduce oxygen delivery to tissues.
Causes and mechanism
Most pulmonary emboli originate from clots in the deep veins of the legs or pelvis; pieces break free and are carried to the pulmonary arterial circulation. Other types of embolic material include clumped cancer cells, fragments of tumor or invasive growths (tumor emboli), fat released after fractures of large bones, and rarely bone marrow or amniotic fluid in specific settings. The lodgment site, embolus size, and the patient’s existing cardiopulmonary reserve determine clinical impact.
Risk factors and pathophysiology
Factors that increase the risk of clot formation include prolonged immobility, recent surgery or trauma, active cancer, pregnancy and the postpartum period, use of certain hormonal therapies, and inherited or acquired clotting disorders. When an embolus obstructs a pulmonary artery, it raises pulmonary vascular resistance, can reduce left ventricular preload, and may precipitate low blood pressure and shock in severe cases.
Symptoms and clinical features
Symptoms often appear suddenly and can include shortness of breath, chest pain that may worsen with breathing, rapid breathing or heart rate, coughing (sometimes with blood-streaked sputum), lightheadedness, or fainting. Small emboli may cause minimal or nonspecific symptoms and be detected incidentally.
Diagnosis
Diagnosis typically combines a clinical assessment with imaging and laboratory tests. Common tools include pulse oximetry, blood tests such as D-dimer when suspicion is low to moderate, chest imaging like computed tomography pulmonary angiography, ventilation–perfusion scanning, and ultrasound of the legs to seek a source clot. Clinical scoring systems help guide testing and urgency of treatment.
Treatment and prevention
- Initial treatment often focuses on anticoagulation to stop further clot growth and allow natural clot breakdown.
- In large or life-threatening emboli, thrombolytic drugs, catheter-directed clot removal, or surgical embolectomy may be considered.
- Supportive care includes oxygen and hemodynamic support when needed.
- Prevention targets risk factors: early mobilization after surgery, use of compression devices, appropriate anticoagulant prophylaxis in high-risk patients, and managing underlying conditions such as malignancy.
Complications and outlook
Complications include persistent shortness of breath, chronic thromboembolic pulmonary hypertension in a minority of cases, and right heart dysfunction. Prompt recognition and treatment improve outcomes, and long-term management may require extended anticoagulation depending on underlying risk. For reliable patient information and clinical resources, see related guidance and summaries at lung health, professional guidelines at vascular care, and specialist oncology or trauma sources for non-thrombotic emboli referenced here and here. Additional practical advice on fracture-related emboli and fat embolism can be found here and here.

